BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15838408)

  • 1. Use of preventive services by Medicare fee-for-service beneficiaries: does spillover from managed care matter?
    Koroukian SM; Litaker D; Dor A; Cooper GS
    Med Care; 2005 May; 43(5):445-52. PubMed ID: 15838408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening in the elderly population: disparities by dual Medicare-Medicaid enrollment status.
    Koroukian SM; Xu F; Dor A; Cooper GS
    Health Serv Res; 2006 Dec; 41(6):2136-54. PubMed ID: 17116113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Medicare cost-sharing elimination for Cancer screening on utilization.
    Xu WY; Wickizer TM; Jung JK
    BMC Health Serv Res; 2019 Jun; 19(1):392. PubMed ID: 31208422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time.
    Doubeni CA; Laiyemo AO; Young AC; Klabunde CN; Reed G; Field TS; Fletcher RH
    Ann Fam Med; 2010; 8(4):299-307. PubMed ID: 20644184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF; Warren JL; Potosky AL; Klabunde CN; Harlan LC; Osswald MB
    Med Care; 2008 Oct; 46(10):1108-15. PubMed ID: 18815533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of performance of traditional Medicare vs Medicare managed care.
    Landon BE; Zaslavsky AM; Bernard SL; Cioffi MJ; Cleary PD
    JAMA; 2004 Apr; 291(14):1744-52. PubMed ID: 15082702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospice use among Medicare managed care and fee-for-service patients dying with cancer.
    McCarthy EP; Burns RB; Ngo-Metzger Q; Davis RB; Phillips RS
    JAMA; 2003 May; 289(17):2238-45. PubMed ID: 12734135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Medicare coverage on use of invasive colorectal cancer screening tests.
    Ko CW; Kreuter W; Baldwin LM
    Arch Intern Med; 2002 Dec 9-23; 162(22):2581-6. PubMed ID: 12456230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries.
    O'Malley AS; Forrest CB; Feng S; Mandelblatt J
    Arch Intern Med; 2005 Oct; 165(18):2129-35. PubMed ID: 16217003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer preventive services, socioeconomic status, and the Affordable Care Act.
    Cooper GS; Kou TD; Dor A; Koroukian SM; Schluchter MD
    Cancer; 2017 May; 123(9):1585-1589. PubMed ID: 28067955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managed care and the diffusion of endoscopy in fee-for-service Medicare.
    Mobley LR; Subramanian S; Koschinsky J; Frech HE; Trantham LC; Anselin L
    Health Serv Res; 2011 Dec; 46(6pt1):1905-27. PubMed ID: 22092022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?
    Keating NL; Landrum MB; Meara E; Ganz PA; Guadagnoli E
    J Natl Cancer Inst; 2005 Feb; 97(4):257-64. PubMed ID: 15713960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the Health Care Experiences of Medicare Beneficiaries with and without Depressive Symptoms in Medicare Managed Care versus Fee-for-Service.
    Martino SC; Elliott MN; Haviland AM; Saliba D; Burkhart Q; Kanouse DE
    Health Serv Res; 2016 Jun; 51(3):1002-20. PubMed ID: 26368572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in cataract extraction rates in Medicare prepaid and fee-for-service settings.
    Goldzweig CL; Mittman BS; Carter GM; Donyo T; Brook RH; Lee P; Mangione CM
    JAMA; 1997 Jun; 277(22):1765-8. PubMed ID: 9178788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal occult blood test use by Kansas medicare beneficiaries.
    Engelman KK; Ellerbeck EF; Ahluwalia JS; Nazir N; Velasco A
    Prev Med; 2001 Dec; 33(6):622-6. PubMed ID: 11716659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer.
    Gross CP; Andersen MS; Krumholz HM; McAvay GJ; Proctor D; Tinetti ME
    JAMA; 2006 Dec; 296(23):2815-22. PubMed ID: 17179458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.